Federal officials from the U.S. Food and Drug Administration (FDA) met this week for a wide-ranging educational webinar about cannabis, outlining matters such as the plant’s chemical makeup, differences between marijuana and hemp, clinical and therapeutic effects of cannabinoids as well as ongoing health and safety concerns around the drug’s use.

Hosted by FDA’s Division of Drug Information, which is part of the agency’s Center for Drug Evaluation and Research (CDER), the webinar was designed to provide information “targeting the needs of all health care professionals, including physicians, physician assistants, nurse practitioners, nurses, pharmacists, pharmacy technicians, and certified public health professionals.”

Read the full article HERE.